Safety and Feasibility of St. Mark's Electrode for the Hypoglossal Nerve and Cortico-lingual Pathway Study
1 other identifier
interventional
10
1 country
1
Brief Summary
The possibility of registering the M-response and the motor evoked potential (MEP) from the muscles of the tongue by using the St. Mark's electrode will be evaluated. The safety of method will be confirmed. Registered parameters will be compared with other known methods and comparative effectiveness of proposed method will be determined. The study will involve healthy volunteers without clinical symptoms of hypoglossal nerve and cortico-lingual pathway lesions and without surgical interventions in the tongue .The volunteers will be examined once for the parameters of the amplitude and latency of the M-response and MEP, as well as the difference between these indicators at different sides of the examination during nerve conduction study (NCS) and transcranial magnetic stimulation (TMS) of the hypoglossal nerve and the cortico-lingual pathway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable healthy-volunteers
Started Oct 2021
Shorter than P25 for not_applicable healthy-volunteers
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedFirst Posted
Study publicly available on registry
October 7, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2021
CompletedNovember 26, 2021
November 1, 2021
19 days
September 23, 2021
November 24, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Severe adverse reactions and events rate
Severe adverse reactions and events will be monitored and registered during procedure of nerve stimulation and on the day of study
During the intervention and 1 day after the intervention
Secondary Outcomes (2)
Rate of M-wave registration during NCS of hypoglossus nerve using the St. Mark's electrode in healthy volunteers.
During the intervention
Rate of MEP registration during TMS of cortical-lingual pathway using the St. Mark's electrode in healthy volunteers.
During the intervention
Study Arms (1)
Hypoglossal nerve conduction study.
EXPERIMENTALInterventions
NCS of nervus hypoglossus (evaluation of M-response parameters) was carried out using a 4-channel electromyographic machine. The stimulation will be carried out from three points: 1. angle of the lower jaw (proximal point), 2. the area of the carotid triangle (distal point), 3. directly from the electrode of St. Mark when it is localized on the muscles of the tongue. The initial stimulation parameters: strength of an electric current 20 mA, stimulus duration 0.2 ms, and frequency 1 Hz. To achieve supramaximal stimulation, the stimulation strength will be increased with a step of 1-2 mA to a maximum of 35 mA, the duration of the stimulus will be increased to 0.3 ms.
TMS will be carried out using a Magstim 200 magnetic stimulator connected with a BiStim module (Magstim Co. Ltd., Whitland, Wales, UK). The generated magnetic pulses will be delivered by the coil 65 mm in diameter tangentially located relative to the scalp in the F7 projection - T3 and F8-T4 (according to the international scheme "10-20"). The area of cortical stimulation will be localized by supplying single pulses with gradual increase, with a coil displacement with a step of 1 cm, until the contraction of the facial muscles will be obtained, followed by the determination of the MEP threshold value. Analysis of conduction by cortical-lingual pathway will be performed at TMS with magnetic stimulus intensity 20-30% above the MEP threshold.
Eligibility Criteria
You may qualify if:
- Absence of clinical symptoms of impaired hypoglossal nerve and cortico-lingual pathways;
- Absence of history of surgical interventions in the tongue area;
- The subject has read the information sheet and signed the informed consent.
You may not qualify if:
- Clinical symptoms of hypoglossal nerve or cortico-lingual pathway (dysarthria, dysphagia (pseudobulbar palsy) lesions, flaccid paralysis of the tongue muscles, atrophy and fasciculations of the tongue muscles);
- Tumors, metastatic lesions and cysts in the region of the brain stem, posterior cranial fossa, base of the skull, in the region of the carotid segment, salivary glands;
- Vascular pathologies in the carotid sinus area: vascular malformations, dissection of the internal carotid artery aneurysm, venous thrombosis;
- Recent dental procedures with one of the following complications: development of an abscess, direct injury to the nerve by medical equipment, development of hematoma;
- History of carotid endarterectomy;
- Motor neuron disease and other neurodegenerative or demyelinating diseases;
- History of cancer and courses of radiation therapy;
- The presence of implantable programmable devices.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pirogov National Medical and Surgical Center
Moscow, 105064, Russia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2021
First Posted
October 7, 2021
Study Start
October 1, 2021
Primary Completion
October 20, 2021
Study Completion
November 10, 2021
Last Updated
November 26, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- 2 months after completion of the study
- Access Criteria
- upon the request